Back to results
US 11,957,761 B2Granted
Compounds having α4β7 integrin inhibition activity
AssigneeZealand Pharma A/S
InventorStefan Schunk
Life of this patent
Estimating the term…
Abstract
Compounds of formula (1): and pharmaceutically acceptable salts and solvates thereof, are described. The compounds are α4β7 antagonists and are useful in the prevention or treatment of inflammatory conditions and/or autoimmune diseases, especially inflammatory bowel disease.
Claims2
A compound of formula (I):
- or a pharmaceutically acceptable salt or solvate thereof.
Dependencies are inferred from the claim text.